Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Mirum pharmaceuticals, inc. source : Www.biospace.com save search
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 11, 2024
Published: 2024-04-11 (Crawled : 07:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -0.35%
H: 1.98%
C: 1.25%
nasdaq pharmaceuticals grants
Mirum Pharmaceuticals’ LIVMARLI (maralixibat oral solution) Receives Positive Reimbursement Recommendation by Canada’s CADTH for Patients with Cholestatic Pruritus in Alagille Syndrome
Published: 2024-04-02 (Crawled : 22:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -1.3%
H: 0.7%
C: 0.36%
pruritus positive livmarli
Mirum Pharmaceuticals’ LIVMARLI Receives FDA Approval for Treatment of Cholestatic Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis
Published: 2024-03-13 (Crawled : 23:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 1.49%
H: 2.98%
C: -0.43%
fda pruritus approval treatment livmarli
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - March 5, 2024
Published: 2024-03-05 (Crawled : 14:30) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.17%
H: 1.04%
C: -2.54%
pharmaceuticals
Hepatology Publishes Six-Year Data Demonstrating Improved Clinical Outcomes in Patients with Alagille Syndrome Treated with Mirum’s LIVMARLI
Published: 2024-02-29 (Crawled : 15:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -1.04%
H: 4.87%
C: 0.42%
livmarli
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2023 Financial Results and Host Conference Call on February 28, 2024
Published: 2024-02-21 (Crawled : 00:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -0.45%
H: 1.28%
C: -2.31%
conference pharmaceuticals financial results
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jan 11, 2024
Published: 2024-01-11 (Crawled : 07:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.04%
H: 3.88%
C: 2.32%
nasdaq pharmaceuticals grants
Mirum Pharmaceuticals Announces Preliminary Unaudited 2023 Net Revenue and Provides Corporate Updates
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -1.39%
H: 0.43%
C: 0.21%
revenue pharmaceuticals
Mirum Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 17:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -0.07%
H: 0.97%
C: -2.0%
conference pharmaceuticals
Mirum Pharmaceuticals to Present at the 2023 Evercore ISI HealthCONx Conference
Published: 2023-11-20 (Crawled : 00:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -0.77%
H: 1.47%
C: 0.09%
conference pharmaceuticals
Mirum Pharmaceuticals to Present at the 2023 UBS Biopharma Conference
Published: 2023-11-03 (Crawled : 22:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 5.32%
H: 3.41%
C: 0.33%
conference biopharma pharmaceuticals
Mirum Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-02 (Crawled : 22:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.28%
H: 1.3%
C: -0.39%
business update pharmaceuticals financial results
Mirum Pharmaceuticals to Present New Data at The Liver Meeting®
Published: 2023-10-30 (Crawled : 13:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.85%
H: 1.21%
C: -0.44%
meeting liver pharmaceuticals
Mirum Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023
Published: 2023-10-27 (Crawled : 19:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: -2.02%
conference pharmaceuticals financial results
Mirum Pharmaceuticals Announces New PDUFA Date for LIVMARLI for the Treatment of Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis
Published: 2023-10-17 (Crawled : 22:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 1.36%
H: 4.07%
C: 2.26%
pruritus treatment pharmaceuticals pdufa livmarli
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 11, 2023
Published: 2023-10-11 (Crawled : 09:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.2%
H: 0.78%
C: -5.97%
nasdaq pharmaceuticals grants
Mirum Pharmaceuticals Announces Positive Phase 3 RESTORE Study Results Evaluating Chenodal in Patients with Cerebrotendinous Xanthomatosis
Published: 2023-10-02 (Crawled : 13:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.0%
H: 0.63%
C: -7.28%
positive pharmaceuticals results study
Mirum Pharmaceuticals to Highlight LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
Published: 2023-09-26 (Crawled : 14:00) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.55%
H: 1.61%
C: -2.41%
pharmaceuticals meeting livmarli
Mirum Pharmaceuticals to Present at the 2023 Cantor Global Healthcare Conference
Published: 2023-09-21 (Crawled : 14:30) - biospace.com/
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: -0.42%
H: 3.46%
C: 3.13%
conference pharmaceuticals global
Mirum Pharmaceuticals Announces the Appointment of Eric Bjerkholt as Chief Financial Officer
Published: 2023-09-11 (Crawled : 19:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: -17.86%
H: 0.0%
C: -34.78%
MIRM | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 0.07%
H: 3.43%
C: 2.29%
CERS | News | $1.675 2.13% 2.09% 980K
|
Health Technology
|
| O: 3.05%
H: 0.0%
C: -0.59%
pharmaceuticals financial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.